INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
SEC FORM 4/Tax withholdingVerified data

Nabiey Romin reported GDRX

Chief Accounting Officer · GoodRx Holdings, Inc. · Class A Common Stock

Side
F
Value
$14K
Shares
4,531
Price
$3.11
Executed
Nov 8, 2025
Disclosed
Nov 10, 2025
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Nov 8 executedNov 10, 2025 disclosed

GDRX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Tax withholding — administrative, little informational value

  • Relative size+1 / 25

$14K reported value · 3.0% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · GDRX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    13
    HJ
    Hirsch Douglas JosephDirector
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    20.5K sh
    		Oct 26, 2026Oct 26, 2026
    traded Oct 26, 2026
    		+0dSEC FORM 4

    Evidence

    9
    HJ
    Hirsch Douglas JosephDirector
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    20.5K sh
    		Oct 26, 2026Oct 26, 2026
    traded Oct 26, 2026
    		+0dSEC FORM 4

    Evidence

    21
    FJ
    Fengler JustinSee Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    32.5K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    13
    FJ
    Fengler JustinSee Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    32.5K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    13
    BL
    Barnes Wendy LynnDirector, See Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    115.1K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    12
    BL
    Barnes Wendy LynnDirector, See Remarks
    GDRXGoodRx Holdings, Inc.
    Tax withholding
    		F$75K
    22.2K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    13
    BL
    Barnes Wendy LynnDirector, See Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    51.2K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    17
    CT
    Chan Thomas (TC)Chief Accounting Officer
    GDRXGoodRx Holdings, Inc.
    Tax withholding
    		F$9,964
    2,948 sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    16
    BL
    Barnes Wendy LynnDirector, See Remarks
    GDRXGoodRx Holdings, Inc.
    Tax withholding
    		F$169K
    50.0K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    13
    CT
    Chan Thomas (TC)Chief Accounting Officer
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    5,793 sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    13
    BL
    Barnes Wendy LynnDirector, See Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    111.0K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    16
    BL
    Barnes Wendy LynnDirector, See Remarks
    GDRXGoodRx Holdings, Inc.
    Tax withholding
    		F$163K
    48.2K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    17
    CT
    Chan Thomas (TC)Chief Accounting Officer
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    5,793 sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    13
    BL
    Barnes Wendy LynnDirector, See Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    111.0K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    9
    BL
    Barnes Wendy LynnDirector, See Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    51.2K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    17
    FJ
    Fengler JustinSee Remarks
    GDRXGoodRx Holdings, Inc.
    Tax withholding
    		F$48K
    14.2K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    13
    BL
    Barnes Wendy LynnDirector, See Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    115.1K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    17
    CT
    Chan Thomas (TC)Chief Accounting Officer
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    2,101 sh
    		Sep 15, 2026Sep 15, 2026
    traded Sep 15, 2026
    		+0dSEC FORM 4

    Evidence

    17
    FJ
    Fengler JustinSee Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    2,335 sh
    		Sep 15, 2026Sep 15, 2026
    traded Sep 15, 2026
    		+0dSEC FORM 4

    Evidence

    9
    FJ
    Fengler JustinSee Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    2,335 sh
    		Sep 15, 2026Sep 15, 2026
    traded Sep 15, 2026
    		+0dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001809519-25-000146
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Nov 8, 2025
    Published
    Nov 10, 2025
    Ingested by INSIDER
    Nov 5, 04:33 UTC
    Last re-read
    Nov 5, 04:33 UTC

    Extracted facts

    Filer
    Nabiey Romin
    Role
    Chief Accounting Officer
    Transaction
    Tax withholdingAs filed: “F”
    Asset
    GoodRx Holdings, Inc.
    Ticker
    GDRX
    Shares
    4,531
    Price per share
    $3.11
    Value
    $14,091
    Execution date (reported)
    Nov 8, 2025
    Owned after transaction
    153.4K shares
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 4,531
    • Price: $3.11

    = $14,091

    What this establishes

    Nabiey Romin filed this Form 4 reporting a tax withholding of GDRX on Nov 8, 2025. It became public on Nov 10, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Accounting Officer
    Nabiey Romincik:0001924892
    Issuer
    GoodRx Holdings, Inc.cik:0001809519

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.